Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease

Código QR

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) has become one of the most prominent causes of chronic liver diseases and malignancies. However, few therapy has been approved. Radix Bupleuri (RB) is the most frequently used herbal medicine for the treatment of liver diseases. In the current study, we aim t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiaojiaoyang Li, Junde Ge, Yajing Li, Yajie Cai, Qi Zheng, Nana Huang, Yiqing Gu, Qi Han, Yunqian Li, Rong Sun, Runping Liu
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Saikosaponin Nonalcoholic fatty liver disease Lipidome Transcriptome Lipid metabolism Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/cb0a8cdb81264de8a6e3c5022eec608a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice
por: Geng-Ruei Chang, et al.
Publicado: (2021)

Transcriptome and metabolome analysis to reveal major genes of saikosaponin biosynthesis in Bupleurum chinense
por: Yilian He, et al.
Publicado: (2021)

Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
por: Piao Zhou, et al.
Publicado: (2021)

Lipidomic, Transcriptomic, and BSA-660K Single Nucleotide Polymorphisms Profiling Reveal Characteristics of the Cuticular Wax in Wheat
por: Jun Zheng, et al.
Publicado: (2021)

Lipidomic and Ultrastructural Characterization of the Cell Envelope of <named-content content-type="genus-species">Staphylococcus aureus</named-content> Grown in the Presence of Human Serum
por: Kelly M. Hines, et al.
Publicado: (2020)

Analysis of Polybrominated Diphenyl Ethers and Lipid Composition in Human Breast Milk and Their Correlation with Infant Neurodevelopment
por: Ming-Hsien Tsai, et al.
Publicado: (2021)

Association of insulin resistance and non-alcoholic fatty liver disease
por: Ekaterina E. Mishina, et al.
Publicado: (2021)

Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
por: Wen Li, et al.
Publicado: (2021)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
por: Filip R, et al.
Publicado: (2018)

Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway
por: Wu X, et al.
Publicado: (2021)

Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers
por: Roshan Shafiha, et al.
Publicado: (2021)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017)

Identification of Novel <italic toggle="yes">Acinetobacter baumannii</italic> Host Fatty Acid Stress Adaptation Strategies
por: Jhih-Hang Jiang, et al.
Publicado: (2019)

Integrated Lipidomic and Transcriptomic Analysis Reveals Lipid Metabolism in Foxtail Millet (Setaria italica)
por: Haiying Zhang, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
por: Ekaterina E. Mishina, et al.
Publicado: (2017)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)

The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease
por: Kamila Bechynska, et al.
Publicado: (2021)

Effects of different processing methods on the lipid composition of hazelnut oil: A lipidomics analysis
por: Jiayang Sun, et al.
Publicado: (2022)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
por: Shahinul Alam, et al.
Publicado: (2021)

Saikosaponin A and D Inhibit Adipogenesis via the AMPK and MAPK Signaling Pathways in 3T3-L1 Adipocytes
por: Sung Ho Lim, et al.
Publicado: (2021)

Opti-nQL: An Optimized, Versatile and Sensitive Nano-LC Method for MS-Based Lipidomics Analysis
por: Angela Cattaneo, et al.
Publicado: (2021)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
por: A. V. Bogolyubova, et al.
Publicado: (2019)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
por: E. G. Naydanova
Publicado: (2015)

A Lipidomics Atlas of Selected Sphingolipids in Multiple Mouse Nervous System Regions
por: Chunyan Wang, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
por: Liu J, et al.
Publicado: (2021)

Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon
por: Jordi Mayneris-Perxachs, et al.
Publicado: (2021)

The Hitchhiker’s Guide to Untargeted Lipidomics Analysis: Practical Guidelines
por: Dmitrii Smirnov, et al.
Publicado: (2021)

Lipid content and fatty acid profiles in ten species of microalgae
por: Ohse,Silvana, et al.
Publicado: (2015)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
por: Na Fei, et al.
Publicado: (2020)

Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
por: Irina A. Khripun, et al.
Publicado: (2019)

Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan
por: Shen HC, et al.
Publicado: (2014)

Ethanol Extraction of Polar Lipids from <i>Nannochloropsis oceanica</i> for Food, Feed, and Biotechnology Applications Evaluated Using Lipidomic Approaches
por: Tânia Melo, et al.
Publicado: (2021)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Masahiro Matsui, et al.
Publicado: (2021)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani D, et al.
Publicado: (2020)

Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter
por: Gandha N, et al.
Publicado: (2020)

Lipidomic Profiling Identifies Signatures of Poor Cardiovascular Health
por: Irma Magaly Rivas Serna, et al.
Publicado: (2021)